Severe sepsis caused by serious gastrointestinal infection in sJIA patients treated with IL-6 receptor antagonist: a case report

• Prif Awduron: Meng Xu (Awdur), Congcong Liu (Awdur), Lishuang Guo (Awdur), Sirui Yang (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: BMC, 2020-03-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Background Interleukin (IL)-6 plays an essential role in the pathogenesis of systemic juvenile idiopathic arthritis (sJIA). Tocilizumab (TCZ), a kind of biological agent against both membrane and soluble IL-6 receptor, is the only biological agent approved for the treatment of sJIA in China...